The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

December 3, 2019

Conditions

Drug Interaction

Interventions

DRUG

ABT

320 mg, Intravenous infusion

DRUG

RIF

600mg q.d.

Trial Locations (1)

Shanghai Public Health Clinical Center, Shanghai

All Listed Sponsors

lead

Shanghai Public Health Clinical Center

OTHER_GOV

NCT04006353 - The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter